Overview

Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
0
Participant gender:
All
Summary
This study evaluated whether lithium included as part of optimized medication treatment improved overall level of illness, symptoms of mania and depression, and quality of life in people with bipolar disorder.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Lithium Carbonate
Criteria
Inclusion Criteria:

- Meets DSM-IV Criteria for bipolar disorder (type I or II)

- Currently symptomatic, as defined as a Clinical Global Impressions Scale-Bipolar
Version, Overall Severity Index (CGI-BP-S) of greater than or equal to 3

- If taking or has taken lithium, must be off lithium for at least 30 days before study
entry

- If a woman of child bearing potential, agrees to inform their doctor at the earliest
possible time of their plans to conceive, to use adequate contraception (e.g. oral
contraceptives, intrauterine device, barrier methods, total abstinence from
intercourse), and to acknowledge the risks of lithium to the fetus and infant (Depo
Provera is acceptable if it is started 3 months before study entry)

Exclusion Criteria:

- Renal impairment (serum creatinine greater than 1.5 mg/dL)

- Thyroid stimulating hormone (TSH) over 20% above the upper normal limit (participants
maintained on thyroid medication must be euthyroid for at least 3 months before Visit
1)

- History of lithium toxicity that was not caused by mismanagement or overdose

- Other contraindication to lithium (e.g., hypersensitivity to lithium or any component
of the formulation, severe cardiovascular or renal disease, severe debilitation,
dehydration, sodium depletion, pregnancy)

- Currently in crisis such that inpatient hospitalization or other crisis - Participated
in a clinical trial of an investigational drug within the 1 months before study entry

- Pregnant or breastfeeding